Cite
Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study.
MLA
Gupta, Sudeep, et al. “Fixed Dose Combination of Capecitabine and Cyclophosphamide in Metastatic Breast Cancer: Results from THE ENCLOSE Phase 2/3 Randomized Multicenter Study.” Breast, vol. 60, Dec. 2021, pp. 147–54. EBSCOhost, https://doi.org/10.1016/j.breast.2021.09.012.
APA
Gupta, S., Biswas, G., Babu, S., Maksud, T. M., Lakshmaiah, K. C., Patel, J. G., Raja, G., Boya, R. R., Patil, P., Choudhury, K., Bondarde, S. A., Neve, R. S., Bhat, G., Mamillapalli, G., Patel, A. A., Patel, P., Joshi, N., Bajaj, V., & Khan, M. A. (2021). Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study. Breast, 60, 147–154. https://doi.org/10.1016/j.breast.2021.09.012
Chicago
Gupta, Sudeep, Ghanashyam Biswas, Suresh Babu, Tanveer M. Maksud, Kuntegowdennahalli C. Lakshmaiah, Jayanti G. Patel, Gopal Raja, et al. 2021. “Fixed Dose Combination of Capecitabine and Cyclophosphamide in Metastatic Breast Cancer: Results from THE ENCLOSE Phase 2/3 Randomized Multicenter Study.” Breast 60 (December): 147–54. doi:10.1016/j.breast.2021.09.012.